{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:44:35Z","timestamp":1781250275574,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["RPT21145LLA"],"award-info":[{"award-number":["RPT21145LLA"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Xeroderma pigmentosum (XP) is a group of rare hereditary disorders with highly increased risk of skin tumors due to defective DNA repair. Recently we reported 34-fold increased risk of internal tumors in XP patients in comparison with general population. The molecular data and clinical practice on the internal tumors treatment in XP patients is limited and scarcely represented in the medical literature. In this work, we describe young patients with constitutive biallelic deactivation of the <jats:italic>XPC<\/jats:italic> gene developing gynecological tumors with somatic <jats:italic>DICER1<\/jats:italic> mutations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Whole genome sequencing was used to analyze in detail somatic mutational landscape and driver events of these rare tumors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We describe five early-onset gynecological tumors in four xeroderma pigmentosum group C (XP-C) young patients (11 to 19 years old) including vaginal embryonal rhabdomyosarcomas in monozygotic twin sisters, juvenile granulosa-cell tumor of the ovary and poorly differentiated stage IA Sertoli-Leydig cell tumor in 19-years old patient, and FIGO stage IC1 tumor of ovary in 13-years old patient. XP-C ovarian tumors harbor 4.4 times more single base substitutions than sporadic tissue-matched cancers and demonstrate XP-C specific mutation signature with strong transcriptional bias indicating inability of the cells to repair bulky DNA lesions of unknown etiology. A special mode of treatment was applied to avoid usage of chemotherapy which is toxic for XP patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>XP-C status should be accounted for prevention and specific treatment of gynecological tumors in young DNA repair-deficient XP patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s43856-023-00341-6","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T08:02:16Z","timestamp":1691740936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Early-onset gynecological tumors in DNA repair-deficient xeroderma pigmentosum group C patients: a case series"],"prefix":"10.1038","volume":"3","author":[{"given":"Andrey. A.","family":"Yurchenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7603-7828","authenticated-orcid":false,"given":"Brice","family":"Fresneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Borghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Rajabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zora","family":"Tata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Genestie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Sarasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8587-2307","authenticated-orcid":false,"given":"Sergey I.","family":"Nikolaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"341_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02203-1","volume":"17","author":"S Nikolaev","year":"2022","unstructured":"Nikolaev, S., Yurchenko, A. A. & Sarasin, A. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts. Orphanet J. Rare Dis. 17, 104 (2022).","journal-title":"Orphanet J. Rare Dis."},{"key":"341_CR2","doi-asserted-by":"publisher","unstructured":"Yurchenko, A. A. et al. XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-020-19633-9 (2020).","DOI":"10.1038\/s41467-020-19633-9"},{"key":"341_CR3","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. ArXiv 1303, (2013)."},{"key":"341_CR4","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"341_CR5","doi-asserted-by":"publisher","unstructured":"van der Auwera, G. A. et al. GATK Best Practices. Current protocols in bioinformatics \/ editoral board, Andreas D. Baxevanis\u2026 [et al.] https:\/\/doi.org\/10.1002\/0471250953 (2002).","DOI":"10.1002\/0471250953"},{"key":"341_CR6","doi-asserted-by":"publisher","unstructured":"Depristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. https:\/\/doi.org\/10.1038\/ng.806 (2011).","DOI":"10.1038\/ng.806"},{"key":"341_CR7","doi-asserted-by":"publisher","first-page":"E2423","DOI":"10.1002\/humu.22771","volume":"36","author":"AH Ramos","year":"2015","unstructured":"Ramos, A. H. et al. Oncotator: cancer variant annotation tool. Hum. Mutat. 36, E2423\u2013E2429, https:\/\/doi.org\/10.1002\/humu.22771 (2015).","journal-title":"Hum. Mutat."},{"key":"341_CR8","doi-asserted-by":"publisher","first-page":"PO.17.00011","DOI":"10.1200\/po.17.00011","volume":"2017","author":"D Chakravarty","year":"2017","unstructured":"Chakravarty, D. et al. OncoKB: a precision oncology knowledge base. JCO Precis. Oncol. 2017, PO.17.00011, https:\/\/doi.org\/10.1200\/po.17.00011 (2017).","journal-title":"JCO Precis. Oncol."},{"key":"341_CR9","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen, R. & Seshan, V. E. FACETS: Allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 44, e131 (2016).","journal-title":"Nucleic Acids Res."},{"key":"341_CR10","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164\u2013e164 (2010).","journal-title":"Nucleic Acids Res."},{"key":"341_CR11","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3390\/cancers12051308","volume":"12","author":"J Roze","year":"2020","unstructured":"Roze, J. et al. Whole genome analysis of ovarian granulosa cell tumors reveals tumor heterogeneity and a high- grade tp53-specific subgroup. Cancers (Basel) 12, 1308 (2020).","journal-title":"Cancers (Basel)"},{"key":"341_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-019-6041-2","volume":"20","author":"EN Bergstrom","year":"2019","unstructured":"Bergstrom, E. N. et al. SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events. BMC Genom. 20, 1\u201312 (2019).","journal-title":"BMC Genom."},{"key":"341_CR13","doi-asserted-by":"publisher","unstructured":"Blokzijl, F., Janssen, R., van Boxtel, R. & Cuppen, E. MutationalPatterns: comprehensive genome-wide analysis of mutational processes. Genome Med. https:\/\/doi.org\/10.1186\/s13073-018-0539-0 (2018).","DOI":"10.1186\/s13073-018-0539-0"},{"key":"341_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12864-022-08357-3","volume":"23","author":"F Manders","year":"2022","unstructured":"Manders, F. et al. MutationalPatterns: the one stop shop for the analysis of mutational processes. BMC Genom. 23, 134 (2022).","journal-title":"BMC Genom."},{"key":"341_CR15","doi-asserted-by":"publisher","first-page":"100179","DOI":"10.1016\/j.xgen.2022.100179","volume":"2","author":"SMA Islam","year":"2022","unstructured":"Islam, S. M. A. et al. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genom. 2, 100179 (2022).","journal-title":"Cell Genom."},{"key":"341_CR16","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/j.ejca.2012.04.012","volume":"48","author":"V Minard-Colin","year":"2012","unstructured":"Minard-Colin, V. et al. Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: good tolerance profile and efficacy in rhabdomyosarcoma\u2014A report from the Soci\u00e9t\u00e9 Fran\u00e7aise des Cancers et leuc\u00e9mies de l\u2019Enfant et de l\u2019adolescent (SFCE). Eur. J. Cancer 48, 2409\u20132416 (2012).","journal-title":"Eur. J. Cancer"},{"key":"341_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2169\/internalmedicine.56.7866","volume":"56","author":"M Sumiyoshi","year":"2017","unstructured":"Sumiyoshi, M. et al. Alert regarding cisplatin-induced severe adverse events in cancer patients with xeroderma pigmentosum. Intern. Med. 56, 979\u2013982 (2017).","journal-title":"Intern. Med."},{"key":"341_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/10781552211038246","volume":"28","author":"PJ Gilbar","year":"2022","unstructured":"Gilbar, P. J. & Pokharel, K. Severe cisplatin-induced renal toxicity in a patient with xeroderma pigmentosum. J. Oncol. Pharm. Pract. 28, 466\u2013470 (2022).","journal-title":"J. Oncol. Pharm. Pract."},{"key":"341_CR19","doi-asserted-by":"publisher","first-page":"586288","DOI":"10.3389\/fonc.2021.586288","volume":"11","author":"G del Baldo","year":"2021","unstructured":"del Baldo, G. et al. Rhabdoid tumor predisposition syndrome: from clinical suspicion to general management. Front. Oncol. 11, 586288 (2021).","journal-title":"Front. Oncol."},{"key":"341_CR20","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41588-022-01147-3","volume":"54","author":"FJ Rouhani","year":"2022","unstructured":"Rouhani, F. J. et al. Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells. Nat. Genet. 54, 1406\u20131416 (2022).","journal-title":"Nat. Genet."},{"key":"341_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101, https:\/\/doi.org\/10.1038\/s41586-020-1943-3 (2020).","journal-title":"Nature"},{"key":"341_CR22","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1101\/gr.246223.118","volume":"29","author":"M Jager","year":"2019","unstructured":"Jager, M. et al. Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer. Genome Res. 29, 1067\u20131077 (2019).","journal-title":"Genome Res."},{"key":"341_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-022-04712-2","volume":"605","author":"J Kaplanis","year":"2022","unstructured":"Kaplanis, J. et al. Genetic and chemotherapeutic influences on germline hypermutation. Nature 605, 503\u2013508 (2022).","journal-title":"Nature"},{"key":"341_CR24","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/s41379-021-00804-y","volume":"34","author":"FKF Kommoss","year":"2021","unstructured":"Kommoss, F. K. F. et al. Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup. Mod. Pathol. 34, 1558\u20131569 (2021).","journal-title":"Mod. Pathol."},{"key":"341_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ygyno.2017.09.034","volume":"147","author":"KAP Schultz","year":"2017","unstructured":"Schultz, K. A. P. et al. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: clinical and genetic findings from the international ovarian and testicular stromal tumor registry. Gynecol. Oncol. 147, 521\u2013527 (2017).","journal-title":"Gynecol. Oncol."},{"key":"341_CR26","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.3324\/haematol.2019.223370","volume":"105","author":"KA Oetjen","year":"2019","unstructured":"Oetjen, K. A. et al. Predisposition to hematologic malignancies in patients with xeroderma pigmentosum. Haematologica. 105, e144 (2019).","journal-title":"Haematologica."},{"key":"341_CR27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.18632\/oncotarget.27966","volume":"12","author":"M Rubatto","year":"2021","unstructured":"Rubatto, M. et al. Immunotherapy in xeroderma pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review. Oncotarget. 12, 1116 (2021).","journal-title":"Oncotarget."},{"key":"341_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s10637-020-01043-9","volume":"39","author":"JA How","year":"2021","unstructured":"How, J. A. et al. The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial. Investig. New Drugs 39, 829\u2013835 (2021).","journal-title":"Investig. New Drugs"},{"key":"341_CR29","doi-asserted-by":"crossref","unstructured":"Klein, O. et al. Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial. J. Immunother. Cancer 9, (2021).","DOI":"10.1136\/jitc-2021-003156"},{"key":"341_CR30","unstructured":"Satoh, Y. & Nishigori, C. Xeroderma pigmentosum: Clinical aspects. Gann Monographs on Cancer Research 35, Springer New York, NY (1988)."},{"key":"341_CR31","first-page":"89","volume":"27","author":"SG Khan","year":"2006","unstructured":"Khan, S. G. et al. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis 27, 89\u201394 (2006).","journal-title":"Carcinogenesis"},{"key":"341_CR32","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/bjd.12183","volume":"168","author":"S Hadj-Rabia","year":"2013","unstructured":"Hadj-Rabia, S. et al. Unexpected extradermatological findings in 31 patients with xeroderma pigmentosum type C. Br. J. Dermatol. 168, 1109\u20131113 (2013).","journal-title":"Br. J. Dermatol."},{"key":"341_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/bjd.14046","volume":"174","author":"M Jerbi","year":"2016","unstructured":"Jerbi, M. et al. Clinical, genealogical and molecular investigation of the xeroderma pigmentosum type C complementation group in Tunisia. Br. J. Dermatol. 174, 439\u2013443 (2016).","journal-title":"Br. J. Dermatol."},{"key":"341_CR34","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1111\/1346-8138.14340","volume":"45","author":"L Tang","year":"2018","unstructured":"Tang, L. et al. Novel compound heterozygous variants in the XPC gene identified in a Chinese xeroderma pigmentosum group C patient with ovarian teratoma. J. Dermatol. 45, e300\u2013e301 (2018).","journal-title":"J. Dermatol."},{"key":"341_CR35","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1111\/jdv.16405","volume":"34","author":"KM Santiago","year":"2020","unstructured":"Santiago, K. M. et al. Comprehensive germline mutation analysis and clinical profile in a large cohort of Brazilian xeroderma pigmentosum patients. J. Eur. Acad. Dermatol. Venereol. 34, 2394\u20132401 (2020).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"341_CR36","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ijscr.2020.12.019","volume":"78","author":"A Bdioui","year":"2021","unstructured":"Bdioui, A. et al. Inhabitual presentation of Sertoli-Leydig cell tumor of the ovary with xeroderma pigmentosum: case report with review of literature. Int. J. Surg. Case Rep. 78, 288\u2013291 (2021).","journal-title":"Int. J. Surg. Case Rep."},{"key":"341_CR37","doi-asserted-by":"publisher","unstructured":"Bacha, D. et al. 286 Sex cord-stromal tumour with rhadomyosarcomatous contingent heterologous in A 7-year-old girl treated for xeroderma pigmentosum. https:\/\/doi.org\/10.1136\/ijgc-2019-igcs.286 (2019).","DOI":"10.1136\/ijgc-2019-igcs.286"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00341-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00341-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00341-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T18:26:33Z","timestamp":1700072793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00341-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["341"],"URL":"https:\/\/doi.org\/10.1038\/s43856-023-00341-6","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"1 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}